TD Asset Management Inc acquired a new position in Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 92,548 shares of the company's stock, valued at approximately $2,306,000. TD Asset Management Inc owned 0.18% of Kestra Medical Technologies at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently bought and sold shares of the business. Jennison Associates LLC bought a new position in Kestra Medical Technologies in the 1st quarter worth approximately $1,869,000. Caas Capital Management LP purchased a new stake in Kestra Medical Technologies in the 1st quarter worth approximately $1,470,000. Finally, Brown Advisory Inc. purchased a new stake in Kestra Medical Technologies in the 1st quarter worth approximately $13,716,000.
Kestra Medical Technologies Stock Performance
Kestra Medical Technologies stock opened at $15.38 on Friday. The firm's fifty day moving average is $17.51. The company has a debt-to-equity ratio of 0.20, a quick ratio of 6.72 and a current ratio of 6.72. Kestra Medical Technologies, Ltd. has a fifty-two week low of $13.25 and a fifty-two week high of $26.15.
Wall Street Analysts Forecast Growth
Several research firms have issued reports on KMTS. The Goldman Sachs Group lowered their target price on shares of Kestra Medical Technologies from $24.00 to $23.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 16th. Wells Fargo & Company lowered their target price on shares of Kestra Medical Technologies from $28.00 to $27.00 and set an "overweight" rating on the stock in a research note on Thursday, July 17th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $27.33.
Read Our Latest Report on KMTS
Kestra Medical Technologies Company Profile
(
Free Report)
We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Kestra Medical Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kestra Medical Technologies wasn't on the list.
While Kestra Medical Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
